• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immunization by a bacterial aerosol.通过细菌气溶胶进行免疫接种。
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4656-60. doi: 10.1073/pnas.0800043105. Epub 2008 Mar 14.
2
Aerosol immunization by alginate coated mycobacterium (BCG/MIP) particles provide enhanced immune response and protective efficacy than aerosol of plain mycobacterium against M.tb. H37Rv infection in mice.海藻酸钠包裹分枝杆菌(BCG/MIP)颗粒的气溶胶免疫比单纯分枝杆菌气溶胶对 H37Rv 感染小鼠提供更强的免疫应答和保护效果。
BMC Infect Dis. 2019 Jul 1;19(1):568. doi: 10.1186/s12879-019-4157-2.
3
Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.用牛分枝杆菌卡介苗进行气溶胶免疫后小鼠的少菌型结核病
Infect Immun. 2004 Feb;72(2):1065-71. doi: 10.1128/IAI.72.2.1065-1071.2004.
4
Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.表达 ESAT6-CFP10 融合蛋白的重组耻垢分枝杆菌诱导抗分枝杆菌免疫应答,并保护小鼠免受结核分枝杆菌攻击。
Scand J Immunol. 2010 Oct;72(4):349-57. doi: 10.1111/j.1365-3083.2010.02448.x.
5
Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin.鸟分枝杆菌-胞内分枝杆菌感染及卡介苗的保护作用。
J Infect Dis. 1982 May;145(5):733-41. doi: 10.1093/infdis/145.2.733.
6
Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.在高度易感动物模型中,表达结核分枝杆菌30 kDa主要分泌蛋白的重组卡介苗(BCG)疫苗比传统卡介苗疫苗诱导出更强的抗结核保护性免疫。
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13853-8. doi: 10.1073/pnas.250480397.
7
Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route.呼吸道感染强毒结核分枝杆菌的豚鼠,干扰素-γ和肿瘤坏死因子-α信使 RNA 的表达与保护无关。
Immunology. 2009 Sep;128(1 Suppl):e296-305. doi: 10.1111/j.1365-2567.2008.02962.x. Epub 2008 Nov 7.
8
A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG.一种新型的抗牛结核病的活重组分枝杆菌疫苗,其效力比卡介苗更强。
Vaccine. 2006 Mar 6;24(10):1593-600. doi: 10.1016/j.vaccine.2005.10.002. Epub 2005 Oct 11.
9
The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.用鸟分枝杆菌进行预致敏后活结核疫苗的疗效。
Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):73-9. doi: 10.1016/j.tube.2004.09.007. Epub 2004 Dec 28.
10
Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs.脂蛋白LpqS缺陷的结核分枝杆菌突变体在体内毒力减弱,在豚鼠中显示出比卡介苗更好的保护效果。
Vaccine. 2016 Feb 3;34(6):735-43. doi: 10.1016/j.vaccine.2015.12.059. Epub 2016 Jan 5.

引用本文的文献

1
Repurposing mucosal delivery devices for live attenuated tuberculosis vaccines.重新利用黏膜递送装置用于减毒活结核疫苗。
Front Immunol. 2023 Mar 30;14:1159084. doi: 10.3389/fimmu.2023.1159084. eCollection 2023.
2
Advance in strategies to build efficient vaccines against tuberculosis.构建高效抗结核疫苗策略的进展
Front Vet Sci. 2022 Nov 24;9:955204. doi: 10.3389/fvets.2022.955204. eCollection 2022.
3
Polymeric Nanoparticles for Inhaled Vaccines.用于吸入式疫苗的聚合物纳米颗粒
Polymers (Basel). 2022 Oct 21;14(20):4450. doi: 10.3390/polym14204450.
4
A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19.一个世纪的卡介苗接种:免疫机制、动物模型、非传统途径及其对 COVID-19 的影响。
Front Immunol. 2022 Aug 26;13:959656. doi: 10.3389/fimmu.2022.959656. eCollection 2022.
5
Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives.纳米技术在治疗呼吸道感染方面的新兴策略:实现当前趋势,展望未来临床应用。
Drug Deliv. 2022 Dec;29(1):2442-2458. doi: 10.1080/10717544.2022.2089294.
6
Aerosolized Intratracheal Inoculation of Recombinant Protective Antigen (rPA) Vaccine Provides Protection Against Inhalational Anthrax in B10.D2-Hc Mice.气溶胶气管内接种重组保护性抗原(rPA)疫苗可预防 B10.D2-Hc 小鼠吸入性炭疽。
Front Immunol. 2022 Jan 26;13:819089. doi: 10.3389/fimmu.2022.819089. eCollection 2022.
7
Complete Protection Against in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein Aerosolized Intratracheal Inoculation.通过雾化吸入途径接种 rF1-V10 融合蛋白吸入制剂免疫 BALB/c 小鼠模型诱导产生的 完全保护作用。
Front Immunol. 2022 Jan 26;13:793382. doi: 10.3389/fimmu.2022.793382. eCollection 2022.
8
Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection.肺脏 MTBVAC 疫苗接种可诱导与预防结核感染相关的免疫特征。
Cell Rep Med. 2021 Jan 19;2(1):100187. doi: 10.1016/j.xcrm.2020.100187.
9
Vaccines Against Tuberculosis: Problems and Prospects (Review).抗结核疫苗:问题与前景(综述)
Appl Biochem Microbiol. 2020;56(5):497-504. doi: 10.1134/S0003683820050129. Epub 2020 Sep 22.
10
Integrating fish models in tuberculosis vaccine development.将鱼类模型整合到结核病疫苗开发中。
Dis Model Mech. 2020 Aug 23;13(8):dmm045716. doi: 10.1242/dmm.045716.

本文引用的文献

1
Pulmonary vaccine delivery.肺部疫苗递送
Expert Rev Vaccines. 2007 Apr;6(2):213-26. doi: 10.1586/14760584.6.2.213.
2
Drying a tuberculosis vaccine without freezing.在不冷冻的情况下干燥结核疫苗。
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2591-5. doi: 10.1073/pnas.0611430104. Epub 2007 Feb 13.
3
Pulmonary DNA vaccination: concepts, possibilities and perspectives.肺部DNA疫苗接种:概念、可能性与前景。
J Control Release. 2005 Sep 20;107(1):1-29. doi: 10.1016/j.jconrel.2005.05.028.
4
Immunology of tuberculosis and implications in vaccine development.结核病免疫学及其在疫苗研发中的意义。
Tuberculosis (Edinb). 2004;84(1-2):93-101. doi: 10.1016/j.tube.2003.08.010.
5
Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development.颗粒形态对肺部给药的基本影响:斯托克斯定律的预测以及与干粉吸入剂配方和开发的特殊相关性。
Pharm Res. 2002 Mar;19(3):239-45. doi: 10.1023/a:1014426530935.
6
Descriptors of irregular particle morphology and powder properties.不规则颗粒形态和粉末性质的描述符。
Adv Drug Deliv Rev. 1997 Jun 9;26(1):29-40. doi: 10.1016/s0169-409x(97)00508-5.
7
Effect of particle morphology on emitted dose of fatty acid-treated disodium cromoglycate powder aerosols.颗粒形态对脂肪酸处理的色甘酸钠粉末气雾剂释放剂量的影响。
Pharm Dev Technol. 1997 Feb;2(1):67-79. doi: 10.3109/10837459709022610.
8
Large porous particles for pulmonary drug delivery.用于肺部药物递送的大孔颗粒。
Science. 1997 Jun 20;276(5320):1868-71. doi: 10.1126/science.276.5320.1868.
9
BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route.通过呼吸道途径接种并攻击的豚鼠中卡介苗诱导的保护作用。
Tuber Lung Dis. 1993 Feb;74(1):38-46. doi: 10.1016/0962-8479(93)90067-8.
10
Aerogenic BCG vaccination against tuberculosis in animal and human subjects.动物和人类受试者中用于预防结核病的卡介苗气溶胶接种。
J Asthma Res. 1968 Jun;5(4):309-23. doi: 10.3109/02770906809100348.

通过细菌气溶胶进行免疫接种。

Immunization by a bacterial aerosol.

作者信息

Garcia-Contreras Lucila, Wong Yun-Ling, Muttil Pavan, Padilla Danielle, Sadoff Jerry, Derousse Jessica, Germishuizen Willem Andreas, Goonesekera Sunali, Elbert Katharina, Bloom Barry R, Miller Rich, Fourie P Bernard, Hickey Anthony, Edwards David

机构信息

University of North Carolina, Chapel Hill, NC 27599-7360, USA.

出版信息

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4656-60. doi: 10.1073/pnas.0800043105. Epub 2008 Mar 14.

DOI:10.1073/pnas.0800043105
PMID:18344320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2290758/
Abstract

By manufacturing a single-particle system in two particulate forms (i.e., micrometer size and nanometer size), we have designed a bacterial vaccine form that exhibits improved efficacy of immunization. Microstructural properties are adapted to alter dispersive and aerosol properties independently. Dried "nanomicroparticle" vaccines possess two axes of nanoscale dimensions and a third axis of micrometer dimension; the last one permits effective micrometer-like physical dispersion, and the former provides alignment of the principal nanodimension particle axes with the direction of airflow. Particles formed with this combination of nano- and micrometer-scale dimensions possess a greater ability to aerosolize than particles of standard spherical isotropic shape and of similar geometric diameter. Here, we demonstrate effective application of this biomaterial by using the live attenuated tuberculosis vaccine bacille Calmette-Guérin (BCG). Prepared as a spray-dried nanomicroparticle aerosol, BCG vaccine exhibited high-efficiency delivery and peripheral lung targeting capacity from a low-cost and technically simple delivery system. Aerosol delivery of the BCG nanomicroparticle to normal guinea pigs subsequently challenged with virulent Mycobacterium tuberculosis significantly reduced bacterial burden and lung pathology both relative to untreated animals and to control animals immunized with the standard parenteral BCG.

摘要

通过制造具有两种颗粒形式(即微米尺寸和纳米尺寸)的单颗粒系统,我们设计了一种免疫效果更佳的细菌疫苗形式。调整微观结构特性以分别改变分散性和气溶胶特性。干燥的“纳米微粒”疫苗具有两个纳米级尺寸的轴和一个微米级尺寸的轴;后者允许实现类似微米级的有效物理分散,而前者使主要纳米尺寸颗粒轴与气流方向对齐。由这种纳米级和微米级尺寸组合形成的颗粒比具有相似几何直径的标准球形各向同性颗粒具有更强的雾化能力。在此,我们通过使用减毒活结核疫苗卡介苗(BCG)证明了这种生物材料的有效应用。制成喷雾干燥纳米微粒气雾剂的卡介苗疫苗,从低成本且技术简单的给药系统中展现出高效递送和外周肺靶向能力。将卡介苗纳米微粒气溶胶递送至随后受到强毒力结核分枝杆菌攻击的正常豚鼠体内,相对于未治疗动物以及用标准肠胃外卡介苗免疫的对照动物,显著降低了细菌负荷和肺部病理变化。